Table 2.
Study | Mean age |
Sex |
IBS subtype | Type of TCA | Daily dosage | Duration of treatment/follow up (wk) | |
Female | Male | ||||||
Vahedi et al[16], 2008 | 36 | 21 | 29 | D-IBS | Amitriptyline | 10 mg | 8 |
Talley et al[17], 2008 | ND | 21 | 13 | D-IBS, C-IBS, Alt-IBS | Imipramine | 2 wk: 25 mg; Thereafter to the end: 50 mg | 12 |
Morgan et al[18], 2005 | 39 | 22 | 0 | D-IBS, C-IBS, Alt-IBS | Amitriptyline | First week: 25 mg; Thereafter to the end: 50 mg | 4 |
Rajagopalan et al[19], 1998 | 34.8 | 11 | 11 | ND | Amitriptyline | First week: 25 mg; 2nd week: 50 mg; Thereafter to the end: 75 mg | 12 |
Vij et al[20], 1991 | 32.5 | 14 | 36 | D-IBS, C-IBS, Alt-IBS | Doxepin | 75 mg | 6 |
Greenbaum et al[21], 1987 | 45.2 | 18 | 11 | D-IBS, C-IBS | Desipramine | First week: 50 mg; 2nd week: 100 mg; Thereafter to the end: 150 mg | 6 |
Tripathi et al[22], 1983 | 37 | ND | ND | ND | Trimipramine | 30 mg | 5 |
IBS: Irritable bowel syndrome; D: Diarrhoea predominant; Alt: Alternating; C: Constipation predominant; TCA: Tricyclic antidepressant.